We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novo Nordisk Hemophilia Drug Flouts Patent, ITC Judge Says

Law360, New York (March 9, 2016, 9:25 PM EST) -- An International Trade Commission judge has ruled that Novo Nordisk AS infringed a Baxalta Inc. patent that is part of a larger investigation into whether Baxter can block allegedly infringing imports...
To view the full article, register now.